U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06794671) titled 'A Basket Trial of Vunakizumab in Inflammatory Skin Diseases' on Jan. 05.
Brief Summary: This is a national multi-center, large sample size case registration clinical study. The registry population was patients with inflammatory skin diseases who were receiving treatment with vunakizumab. All outpatient and inpatient patients with inflammatory skin diseases who were receiving vunakizumab were eligible for enrollment. Patients' usual care was not affected by participation in the study. We only collected data in routine clinical practice.
The study had an enrollment period of 5 years or 10,000 patients were recruited early, whichever ...